medium.com/@medchemexpr...
medium.com/@medchemexpr...
🧬 Marrow Therapeutics Raises $173M for Bone Marrow-Targeted siRNA to Rival CRISPR in Sickle Cell Disease — Marrow Therapeutics, a Watertown, Massachusetts–based biotechnology company, emerged in November 2026 with…
https://crvscience.com/news/marrow-therapeutics-sirna-sickle-cell
🧬 Marrow Therapeutics Raises $173M for Bone Marrow-Targeted siRNA to Rival CRISPR in Sickle Cell Disease — Marrow Therapeutics, a Watertown, Massachusetts–based biotechnology company, emerged in November 2026 with…
https://crvscience.com/news/marrow-therapeutics-sirna-sickle-cell
DeepRNAi: Predicting on- and off-target siRNA activity and establishing a benchmark
https://www.biorxiv.org/content/10.64898/2026.11.12.766311v1
DeepRNAi: Predicting on- and off-target siRNA activity and establishing a benchmark
https://www.biorxiv.org/content/10.64898/2026.11.12.766311v1
https://www.globenewswire.com/news-release/2026/11/13/3402569/0/en/wave-life-sciences-highlights-wve-007-inhbe-sirna-progress-at-obesityweek-2026.html
https://www.globenewswire.com/news-release/2026/11/13/3402569/0/en/wave-life-sciences-highlights-wve-007-inhbe-sirna-progress-at-obesityweek-2026.html
Read more: https://ow.ly/gnZh5107tnI
Read more: https://ow.ly/gnZh5107tnI
Neoplasma · Zhong et al.
doi.org/10.4149/neo_2026_260408n106
#RNAsky #RNAmods
Neoplasma · Zhong et al.
doi.org/10.4149/neo_2026_260408n106
#RNAsky #RNAmods
arxiv.org/abs/2611.15812
arxiv.org/abs/2611.15812
#TMLNews #Health #Wellness #PublicHealth #HealthNews
https://tml.news/stories/fda-approves-livsayis-cemdisiran-myasthenia-gravis/
Follow @tmlnews. The next story is already moving.
#TMLNews #Health #Wellness #PublicHealth #HealthNews
https://tml.news/stories/fda-approves-livsayis-cemdisiran-myasthenia-gravis/
Follow @tmlnews. The next story is already moving.
Dr Paloma Giangrande joins our Board as Non-Executive Director, and Dr James McNamara as Head of Oligonucleotide Therapeutic Development. Both helped pioneer aptamer-mediated siRNA delivery.
polaris.brighterir.com/public/aptam...
#APTA #RNA #aptamers
Dr Paloma Giangrande joins our Board as Non-Executive Director, and Dr James McNamara as Head of Oligonucleotide Therapeutic Development. Both helped pioneer aptamer-mediated siRNA delivery.
polaris.brighterir.com/public/aptam...
#APTA #RNA #aptamers
Season 2, Episode 21: Peak Performance
Aired: 7/10/1989, Syndication
00:20:25.457
https://www.medpagetoday.com/meetingcoverage/aasld/123809
https://www.medpagetoday.com/meetingcoverage/aasld/123809
https://www.medpagetoday.com/meetingcoverage/aasld/123809
https://www.medpagetoday.com/meetingcoverage/aasld/123809
Read their findings for free in RSC Pharmaceutics: pubs.rsc.org/pm/article/d...
Read their findings for free in RSC Pharmaceutics: pubs.rsc.org/pm/article/d...